Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Execution in the US required

Credit Corp
3:27pm
January 31, 2024
CCP’s 1H24 underlying NPAT of A$33.5m (+5% on pcp) missed consensus expectations (>15%) on higher lending provisioning; and high cost growth. CCP held NPAT guidance. The mid-point looks achievable (implied 2H24 NPAT ~A$51.5m), with 2H Lending volumes the main swing factor. Despite the ‘miss’, CCP’s FY25/26 earnings outlook remains largely unchanged. However, the composition skews further to Consumer Lending; and trust in the USA execution is required (only slight incremental US ‘evidence’ in this result). Backing management’s execution in delivering on USA divisional growth expectations over FY25/26 is needed. We think the valuation point (11.5x FY25PE) provides enough upside and risk/reward to do so. Add maintained.

Hitting its targets

Airtasker
3:27pm
January 31, 2024
Airtasker (ART) released a broadly positive 2Q24 trading update in our view, which saw an +8% increase in group revenue to A$12.2m, and the business achieving positive free cash flow for the period. We make upward revisions to our FY25-26F revenue estimates on an improved take-rate (details below). Our DCF/Multiples derived price target increases marginally to A$0.54 (from A$0.53). Add maintained.

Share price over reaction to an exciting outlook

ImpediMed
3:27pm
January 31, 2024
IPD share price has come under selling pressure after the release of its 2Q24 cashflow report which was below expectation. However we believe this is an overreaction with excellent progress being made with private payor coverage. IPD highlight that 13 states in the US have reached critical mass (ie 80% of population covered for reimbursement from private payors or Medicare). The target is that 85% of the US will be providing coverage by the end of FY24. Following a change in management estimates of revenue recognition to equal monthly payments across the term of each contract we have revised our revenue forecast. As a result our DCF based valuation has reduced to A$0.20 (was A$0.22). we maintain our Speculative Buy recommendation.

4Q23 report card

Atlas Arteria
3:27pm
January 30, 2024
The 4Q23 traffic and toll revenue data presented minimal surprises on the key roads that contribute to the bulk of ALX’s equity valuation. 12 month target price lifts 3 cps to $5.61, mostly driven by higher Chicago Skyway toll escalation for FY24 and FY25 than previously assumed. HOLD retained, albeit value does look attractive at current prices with c.10% potential TSR (underwritten by a c.7% cash yield).

Good progress on all fronts

Micro-X
3:27pm
January 30, 2024
MX1 posted its 2Q24 report which showed a net operating cash inflow of A$4.3m which was boosted by the receipt of a R&D rebate of A$6.2m. Pleasingly, Mobile DR receipts are ticking up and project work with the ASA and DHA remain on track. Our focus remains on turning customer and distributor demonstrations of the Argus into sales. At this stage we have made no changes to our forecasts, valuation or target price of A$0.27. We maintain a Speculative Buy recommendation.

Wounded, but can be repaired

Aroa Biosurgery
3:27pm
January 30, 2024
ARX provided a disappointing update at its 3Q24 results, downgrading its FY24 revenue forecasts by ~8% and now expecting a small EBITDA loss (NZ$1-3m) for the year (was positive NZ$1-2m). The downgrade was due to an overestimation of revenue from its distribution partner, TELA Bio and a focus on selective procedures for Myriad. We have reduced our forecasts in line with guidance and have downgraded our target price to $1.20 (was $1.50) but retain our Add recommendation.

Flows trend improving

Netwealth Group
3:27pm
January 30, 2024
NWL reported 2Q24 FUA of A$78bn (+8.3% qoq; +24.6% pcp), with a ~A$3.4bn positive market move and net inflows of A$2.6bn (in-line with expectations). 2Q24 net inflows of A$2.6bn were up ~27% qoq and 25% on the pcp. Net inflows returned to more ‘normalised’ levels as gross outflows slowed. Pooled cash levels are stable (lower revenue margin) and NWL stepped up hiring (low job vacancies). We still expect some incremental margin improvement in 1H. NWL continues to execute and the opportunity runway remains long. The groups market position; earnings defensiveness; and growth outlook is strong, however, the stock is trading in-line with our valuation.

Not better yet, but moving before the evidence

Bapcor
3:27pm
January 29, 2024
BAP’s 1H24 NPAT is expected to be down 13-15% on pcp. Whilst below our forecast (~7%), the trading update was overall in-line with expectations. Retail was weak (EBITDA -13% on pcp), however in-line. Trade divisions +4-5%. BAP reconfirmed Better-than-Before (BTB) targets for 2H24, expecting A$7-10m NPAT. The exit run rate should be greater, given timing through the half. We see the trading update as providing some increased clarity of the core earnings trajectory/base. Whilst there is still earnings risk evident (Retail), FY25 is positioned to see earnings increase (vs FY23/24 which faced downside risks). Several factors remain against the BAP investment case: negative earnings momentum; recent CFO departure; and transformation targets which look unachievable. Whilst hard to hurdle, there is now arguably lower downside earnings risk and higher prospects for earnings improvement into FY25. Coupled with a reasonable valuation (16.5x a re-based FY24), we see this as providing enough risk/reward to accumulate ahead of the firm evidence of the earnings uplift. Upgrade to ADD recommendation.

A good base set for future growth

Frontier Digital Ventures
3:27pm
January 29, 2024
FDV has released its 4Q23 quarterly update. While 4Q23 group revenue was down -13% on the pcp, we saw the quarterly update as mirroring recent trends of a broadly robust performance from FDV’s consolidated businesses, held back by some continued headwinds in Zameen. We adjust our FDV FY23F/FY24F EPS by +2%/-1% on a broad review of our earnings assumptions. Our target price is unchanged at A$0.77. We continue to be attracted to FDV’s long-term growth profile and the earnings potential of the assembled portfolio. ADD rating maintained.

Bauna still delivers

Karoon Energy
3:27pm
January 29, 2024
A quarter with some challenges, in particular impacted Brazil volumes following a hydrate issue and subsequent mechanical failure at one of Bauna’s wells. KAR delivered a largely in-line December quarter operational and sales result. Despite issues Bauna achieved above midpoint of guidance production. Who Dat only contributed 11 days of production at the end of the period. We expect more data (and a much larger contribution) in future periods. We maintain an Add recommendation, with an unchanged A$2.80 Target Price.

News & Insights

Investment Watch is a flagship product that brings together our analysts' view of economic and investment strategy themes, sector outlooks and best stock ideas for our clients.

Investment Watch is a quarterly publication produced by Morgans that delves into key insights for equity and economic strategy. This latest publication will cover;

  • Asset Allocation – not the time to play defence
  • Economic Strategy – averting a world recession
  • Equity Strategy – attention turns to August
  • Resources & Energy – domestic gas coming to the boil
  • Banks – befuddling
  • Updated Morgans Best Ideas

Morgans clients receive exclusive insights such as access to our latest Investment Watch publication. Download the preview now.

      
View Investment Watch
      

Preview

We think the investment landscape remains favourable. The US economic fundamentals are strong with no significant downside risks to growth in the near-term. European leading indicators suggest a turning point is near and China’s cyclical recovery is still gaining momentum after bottoming earlier in the year.

Meanwhile, the Australian economy continues to defy expectations of a sharper slowdown. In our view, this is not the time to play defence and continue to expect growth assets such as equities and property to do well. This quarter, we look at tactical opportunities in private credit, global equities and across the Australian equity market (resources, agriculture, travel and technology).

Read more
Our best ideas are those that we think offer the highest risk-adjusted returns over a 12-month timeframe supported by a higher-than-average level of confidence. They are our most preferred sector exposures.

As interest rates normalise, earnings quality, market positioning and balance sheet strength will play an important role in distinguishing companies from their peers. We think stocks will continue to diverge in performance at the market and sector level, and investors need to take a more active approach than usual to manage portfolios.

Additions: This month we add Elders.

July best ideas

Elders (ELD)

Small cap | Food/Ag

ELD is one of Australia’s leading agribusinesses. It has an iconic brand, 185 years of history and a national distribution network throughout Australia. With the outlook for FY25 looking more positive and many growth projects in place to drive strong earnings growth over the next few years, ELD is a key pick for us. It is also trading on undemanding multiples and offers an attractive dividend yield.

Technology One (TNE)

Small cap | Technology

TNE is an Enterprise Resource Planning (aka Accounting) company. It’s one of the highest quality companies on the ASX with an impressive ROE, nearly $200m of net cash and a 30-year history of growing its earnings by ~15% and its dividend ~10% per annum. As a result of its impeccable track record TNE trades on high PE. With earnings growth looking likely to accelerate towards 20% pa, we think TNE’s trading multiple is likely to expand from here.

ALS Limited

Small cap | Industrials

ALQ is the dominant global leader in geochemistry testing (>50% market share), which is highly cash generative and has little chance of being competed away. Looking forward, ALQ looks poised to benefit from margin recovery in Life Sciences, as well as a cyclical volume recovery in Commodities (exploration). Timing around the latter is less certain, though our analysis suggests this may not be too far away (3-12 months). All the while, gold and copper prices - the key lead indicators for exploration - are gathering pace.

Clearview Wealth

Small cap | Financial Services

CVW is a challenger brand in the Australian retail life insurance market (market size = ~A$10bn of in-force premiums). CVW sees its key points of differentiation as its: 1) reliable/trusted brand; 2) operational excellence (in product development, underwriting and claims management); and 3) diversified distributing network. CVW's significant multiyear Business Transformation Program has, in our view, shown clear signs of driving improved growth and profitability in recent years. We expect further benefits to flow from this program in the near term, and we see CVW's FY26 key business targets as achievable. With a robust balance sheet, and with our expectations for ~21% EPS CAGR over the next three years, we see CVW's current ~11x FY25F PE multiple as undemanding.

GUD Holdings

Large cap | Consumer Discretionary

GUD is a high-quality business with an entrenched market position in its core operations and deep growth opportunities in new markets. We view GUD’s investment case as compelling, a robust earnings base of predominantly non-discretionary products, structural industry tailwinds supporting organic growth and ongoing accretive M&A optionality. We view the ~12x multiple as undemanding given the resilient earnings and long-duration growth outlook for the business ahead.

Stanmore Resources

Small cap | Metals & Mining

SMR’s assets offer long-life cashflow leverage at solid margins to the resilient outlook for steelmaking coal prices. We’re strong believers that physical coal markets will see future cycles of “super-pricing” well above consensus expectations, supporting further periods of elevated cash flows and shareholder returns. We like SMR’s ability to pay sustainable dividends and its inventory of organic growth options into the medium term, with meaningful synergies, and which look under-recognised by the market. We see SMR as the default ASX-listed producer for pure met coal exposure. We maintain an Add and see compelling value with SMR trading at less than 0.8x P/NPV.


Morgans clients receive full access of the Best Ideas, including our large, mid and small-cap key stock picks.

      
Contact us
      
Read more
There are many reasons to invest in equities. Historically, they have offered higher capital returns than many other asset classes. Furthermore, they provide liquidity and diversification and allow investors to participate in the growth of high performing businesses and sectors.

There are many reasons to invest in equities. Historically, they have offered higher capital returns than many other asset classes. Furthermore, they provide liquidity and diversification and allow investors to participate in the growth of high performing businesses and sectors. Not to be overlooked, however, is their capacity to provide an income stream through regular dividends. In the Month Ahead for July, we highlight a selection of Australian equities that offer superior forecast dividend yields and may be suitable investments for those seeking income.

Happy New Financial Year!

BHP Group (BHP)

BHP Group (ASX: BHP) is the largest diversified mining company in the world. BHP has extensive iron ore, copper, nickel and coal operations, and will soon add potash to its portfolio once its massive Jansen project comes online in late 2026. Besides nickel, which has proven volatile, the rest of BHP’s basket of market exposures share the similar characteristic of typically boasting bumper margins throughout the cycle. Over the last decade BHP has shifted its corporate strategy toward streamlining its business, protecting its balance sheet, slowing its pace of investment and maximising shareholder returns. Despite an impressive shareholder performance over recent years, BHP’s dividend yield has remained above market.

      
BHP coverage report
      

Dalrymple Bay Infrastructure (DBI)

Dalrymple Bay Infrastructure (ASX: DBI). DBI owns a fully contracted coal export terminal in central Qld. It has strong revenue and cost risk mitigants, CPI-linked base revenues boosted by incremental revenues from commissioned sustaining capex projects, very high EBITDA margins, and an investment grade credit profile. Investors comfortable with the coal-related exposure also benefit from the ESG discount imputed into the stock price.

      
DBI coverage report
      

Ventia Services Group (VNT)

Ventia Services Group (ASX: VNT) delivers essential services predominantly to government (c.75% of revenue), with an average contract tenure of c.5-7 years and direct inflation passthrough (95% of revenue) in most contracts. The industry grows at 6-7% pa, with VNT growing 7-10% through industry growth and contract expansion, whilst margins should remain stable. The stock continues to deliver a strong dividend yield, which we expect to continue growing at mid-single digits, whilst trading on an undemanding low double-digit PER.

      
VNT coverage report
      

Eagers Automotive (APE)

Eagers Automotive Limited (ASX: APE) is the leading automotive retail group in Australia and New Zealand, operating for over 100 years and representing a diverse portfolio of OEM (original equipment manufacturer) brands. While current industry dynamics in the auto sector (margin pressure; cost of living impacts) are expected to persist in the near-term, we view the scale operators (such as APE) as best placed to navigate this challenging dynamic. Longer-term, we are positive on APE’s various strategic initiatives and expect it can continue to scale; and sustain a structurally higher return on sales through the cycle.

      
APE research report
      

GQG Partners (GQG)

GQG Partners (ASX: GQG) is global asset management boutique, managing ~US$150bn in funds across four primary equity strategies. We like GQG given its highly effective distribution, scalable strategies, and strong long-term investment performance. We view the earnings tailwind from strong funds under management growth (a combination of investment performance and net fund inflows) will continue and we think GQG will continue to re-rate along with this to a higher earnings multiple in time.

      
GQG research report
      

HomeCo Daily Needs REIT (HDN)

HomeCo Daily Needs REIT (ASX: HDN) has a +$4.5bn real estate portfolio focused on daily needs retail (Large Format Retail; Neighbourhood; and Health Services) across +50 properties with the top five tenants being Woolworths, Coles, JB Hi-Fi, Bunnings and Spotlight. Most of leases are fixed. The portfolio has resilient cashflows, with the majority of tenants being national. Sites are in strategic locations with strong population growth. HDN offers an attractive distribution yield, with a +$600m development pipeline providing further growth.

      
HDN research report
      

IPH Limited (IPH)

IPH Limited (ASX: IPH) is a prominent IP services group with market leading shares in Australia, Singapore and Canada. A defensive business, IPH has strong cash flow generation (with high conversion to EBITDA) and a long-track record of paying dividends to shareholders. We like IPH and consider the return to organic growth (albeit subdued) as a key near-term catalyst for the group. Longer-term, we expect IPH to continue to prosecute its consolidation and network expansion strategy offshore.

      
IPH research report
      

Suncorp (SUN)

Suncorp (ASX: SUN) is well positioned to benefit from continued strong price increases going through the home and motor insurance market in Australia, we expect these price increases to be supportive of SUN’s margins expanding further over the next couple of years. Additionally SUN’s recent divestment of its bank was done at an excellent price and will allow the company to focus completely on its strongest business, general insurance, where it is a market leader.  Finally, post the bank sale, SUN now has >A$4bn of excess capital to return to shareholders, which will occur most likely via the way of a share consolidation and a small special dividend.

      
SUN research report
      

Super Retail Group (SUL)

Super Retail Group (ASX: SUL) is a large discretionary retailer comprising four well-known brands which span several categories, including: Supercheap Auto; rebel Sport; Boating, Camping and Fishing (BCF), and Macpac. We like SUL given its market leading scale (>740 stores), deep data capabilities, strong loyalty base and diversified portfolio of brands. SUL has a very strong net cash balance sheet, and we expect it is positioned for further capital management initiatives in the near-term (i.e. potential special dividends).

      
SUL research report
      

Woodside Energy (WDS)

Woodside Energy (ASX: WDS) is the largest ASX-listed oil and gas producer, and in the top 10 globally. While its share price has come under pressure, Woodside’s fundamentals have benefited from resilient oil/LNG prices, steady group production, progress on delivering its key growth projects, a robust level of profitability, and clear focus on its dividend profile. Woodside’s dividend payout ratio has averaged 80% of earnings for the last +5 years, which is impressive given the last 2 years have been a capex-heavy phase as its progressed construction of the Scarborough, Pluto Train 2, and Sangomar projects. With gearing remaining low and cash flow set to grow post the current investment phase, we see Woodside as likely to remain an attractive yield play.

      
WDS research report
      

Morgans clients receive exclusive insights such as access to the latest stock and sector coverage featured in the Month Ahead. Contact us today to begin your journey with Morgans.

      
Contact Us
      
Read more